18 November 2022 – On October 5-6, 2022, ICPerMed organized a hybrid conference entitled “ICPerMed Conference – Prelude to the Future of Medicine” in Paris. Video recordings, presentations and a short conference report are now available.
Personalised medicine aims to deliver the right treatment to the right patient at the right time by relying on specific characteristics of individuals such as information on the lifestyle of patients and citizens or omics data (information or molecular characteristics of a cell or population of cells) in order to better understand the cellular mechanisms that may be disrupted in a given pathology. This includes genomic data for the study of the genome, transcriptomic data for the study of gene expression, proteomic data for the study of proteins etc.
If modern medicine already takes into account the specificities of patients, personalised medicine promises to push this principle much further. It aims to offer tailor-made diagnoses and treatments for everyone, thanks to a detailed knowledge of their health journey, but also of their lifestyle or even their genome. With the increasing knowledge on biological mechanisms underlying diseases and the emergence of Big Data and new technologies, personalised medicine allows to improve diagnostic and risk prediction tools, to develop more targeted therapeutic strategies, to enhance therapeutic decision-making and to implement effective prevention measures.
To become a reality, personalised medicine needs to democratise and to transfer the results obtained in the laboratory into practice. To this end, ICPerMed aims to decipher obstacles and challenges faced for the implementation of personalised medicine and promote solutions facilitating it. That is the reason why ICPerMed tries to establish a common understanding concerning the cost-benefit value for the health system, to engage patients and citizen in their own health, to develop the use of health data and promote innovative ecosystems connecting research, technology and innovation and ensuring scientific breakthroughs can make it to the market. This implies to call on many fields such as data science, human and social sciences, health economics, public health or health regulations and to promote multi- and transdisciplinary approaches.
The ICPerMed conference was structured around 4 keynote lectures, offering a focus on promising examples of targeted treatments or a personalised approach for diagnosis, and around 5 sessions addressing crucial aspects for the successful implementation of personalised medicine.